Tag: OPKO Health

March 21, 2019

OPKO Announces Positive Topline Results In Phase 2 Diabetes And Obesity Trial

OPKO Health (NASDAQ:OPK) has announced positive topline results from a Phase 2 dose escalation trial for OPK88003 to treat type...
March 19, 2019

4 Medical Device FDA Clearances and Approvals So Far in 2019

The FDA continues to ramp up evaluation methods when assessing medical devices; here are four devices cleared or approved so...
May 9, 2018

OPKO Health Reports First Quarter 2018 Financial Results

OPKO Health (NASDAQ:OPK) reports financial results and business highlights for the three months ended March 31, 2018. As quoted in...
March 23, 2018

OPKO Health Enrolls First Patient in Phase 2b Study of OPK88003 to Treat Type 2 Diabetes

OPKO Health (NASDAQ:OPK) has enrolled the first patient in a Phase 2b dose escalation trial of OPK88003, a once-weekly oxyntomodulin therapy...
January 26, 2018

OPKO Health Announces Leadership Changes at BioReference Laboratories

OPKO Health (NASDAQ:OPK), announces that Gregory Henderson, M.D., Ph.D., has resigned from his position as President of BioReference Laboratories, an OPKO...
March 7, 2017

OPKO Subsidiary GenPath Women’s Health Announces Availability Of ClariTest

OPKO Health (NASDAQ:OPK) has announced GenPath Women's Health will begin offering ClariTest, a non-invasive prenatal test, to be performed initially...